HOME   |    PDF   |   


Title

Repurposing of traditional Siddha drug for external application in chronic irritant contact dermatitis – A case report

 

Authors

Ulagamadhavan Muthuraj 1,*, Varshini Kumar 1, R. Keerthika 2, Shakthi Paargavi Ambalavanan 1, R. Gayatri 1, Srinivasan Venkatachalam 1, Ramamurthy Murugan 1, Elansekaran Selladurai 1 & Gnanaraj Johnson Christian 1

 

Affiliation

1Department of Noi Naadal, National Institute of Siddha, Chennai, India; 2Department of Pura Maruthuvam, National Institute of Siddha, Chennai, India; *Corresponding author

 

Email

Ulagamadhavan Muthuraj - E-mail: ulagamadhavanSiddha@outlook.com
Varshini Kumar - E-mail: varshini98kumar@gmail.com
R. Keerthika - E-mail: keerthika93@gmail.com
Shakthi Paargavi Ambalavanan - E-mail: spaargavi@gmail.com
R. Gayatri - E-mail: poppysmart126@gmail.com
Srinivasan Venkatachalam - E-mail: seenunis47@gmail.com
Ramamurthy Murugan - E-mail: ramsnis@gmail.com
Elansekaran Selladurai - E-mail: sekarnis78@gmail.com
Gnanaraj Johnson Christian - E-mail: christianvijila@gmail.com
 

Article Type

Views

 

Date

Received October 1, 2026; Revised October 31, 2026; Accepted October 31, 2026, Published October 31, 2026

 

Abstract

Siddha system of medicine offers several drugs for managing skin disorders, including contact dermatitis. Hence, a maiden attempt was made to repurpose an internal medicine for external application in chronic irritant contact dermatitis. A 30-year-old tea vendor with an 8-year history was treated with the drug, containing chestnut as its chief ingredient and occupational avoidance for 14 days. Complete resolution of dermatitis and symptoms was observed, with no recurrence during 12 months of drugless follow-up. However, well-designed clinical trials are required to evaluate its efficacy.

 

Keywords

Dermatology, irritant contact dermatitis, karappan, moolakudara thylam, case report, Siddha

 

Citation

Muthuraj et al. Bioinformation 22(10): 6549-6553 (2026)

 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.